| Primary |
| Drug Use For Unknown Indication |
17.2% |
| Hypertension |
11.5% |
| Pain |
6.9% |
| Cardiovascular Disorder |
5.7% |
| Gout |
5.7% |
| Pulmonary Arterial Hypertension |
5.7% |
| Cardiac Failure Congestive |
4.6% |
| Coronary Artery Disease |
4.6% |
| Depression |
4.6% |
| Systemic Lupus Erythematosus |
4.6% |
| Anxiety |
3.4% |
| Cardiac Failure |
3.4% |
| Fluid Retention |
3.4% |
| Hypothyroidism |
3.4% |
| Polyuria |
3.4% |
| Asthma |
2.3% |
| Constipation |
2.3% |
| Diabetes Mellitus |
2.3% |
| Diuretic Therapy |
2.3% |
| Mantle Cell Lymphoma |
2.3% |
|
| Death |
17.6% |
| Renal Failure Acute |
8.8% |
| Dehydration |
5.9% |
| Hypokalaemia |
5.9% |
| Post-traumatic Stress Disorder |
5.9% |
| Pulmonary Arterial Hypertension |
5.9% |
| Sinusitis |
5.9% |
| Tremor |
5.9% |
| Ventricular Extrasystoles |
5.9% |
| Diverticulitis |
2.9% |
| Drug Ineffective |
2.9% |
| Fibrocystic Breast Disease |
2.9% |
| Helicobacter Gastritis |
2.9% |
| Myocardial Infarction |
2.9% |
| Optic Nerve Injury |
2.9% |
| Pain In Extremity |
2.9% |
| Palpitations |
2.9% |
| Paralysis |
2.9% |
| Pharmaceutical Product Complaint |
2.9% |
| Pruritus |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
46.5% |
| Hypertension |
15.7% |
| Drug Use For Unknown Indication |
4.9% |
| Osteoporosis |
3.8% |
| Pain |
3.8% |
| Ventricular Tachycardia |
3.2% |
| Coronary Artery Disease |
2.7% |
| Depression |
2.7% |
| Immunosuppression |
2.2% |
| Cardiac Failure |
1.6% |
| Diuretic Therapy |
1.6% |
| Gout |
1.6% |
| Idiopathic Pulmonary Fibrosis |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
| Anaemia |
1.1% |
| Anxiety |
1.1% |
| Atrial Fibrillation |
1.1% |
| Back Pain |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Constipation |
1.1% |
|
| Myocardial Infarction |
12.8% |
| Syncope |
12.8% |
| Myalgia |
7.7% |
| Visual Disturbance |
7.7% |
| Weight Decreased |
7.7% |
| Drug Hypersensitivity |
5.1% |
| Pruritus |
5.1% |
| Transplant Failure |
5.1% |
| Tremor |
5.1% |
| Ventricular Tachycardia |
5.1% |
| Blood Pressure Decreased |
2.6% |
| Coagulopathy |
2.6% |
| Henoch-schonlein Purpura |
2.6% |
| Hypertension |
2.6% |
| Hypokalaemia |
2.6% |
| Presyncope |
2.6% |
| Pulmonary Arterial Hypertension |
2.6% |
| Supraventricular Tachycardia |
2.6% |
| Ventricular Extrasystoles |
2.6% |
| Vulvovaginal Mycotic Infection |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.8% |
| Drug Use For Unknown Indication |
18.0% |
| Hypertension |
8.7% |
| Pain |
6.9% |
| Diabetes Mellitus |
4.7% |
| Nuclear Magnetic Resonance Imaging |
4.6% |
| Pulmonary Arterial Hypertension |
3.7% |
| Type 2 Diabetes Mellitus |
3.0% |
| Angiogram |
2.9% |
| Atrial Fibrillation |
2.6% |
| Cardiac Disorder |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Rash |
2.1% |
| Prostate Cancer |
2.1% |
| Proteus Infection |
2.1% |
| Pseudomonas Infection |
2.1% |
| Hormone Replacement Therapy |
2.0% |
| Pulmonary Hypertension |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Breast Cancer Metastatic |
1.7% |
|
| Vomiting |
12.9% |
| Weight Increased |
12.4% |
| Nausea |
7.9% |
| Myocardial Infarction |
6.7% |
| Death |
6.0% |
| Weight Decreased |
6.0% |
| Renal Failure |
5.2% |
| Pain |
4.8% |
| Oedema Peripheral |
4.5% |
| Swelling |
3.8% |
| Dyspnoea |
3.6% |
| Urinary Tract Infection |
3.6% |
| Wound |
3.6% |
| Muscle Spasms |
3.1% |
| Wheezing |
3.1% |
| Thrombocytopenia |
2.9% |
| Diabetes Mellitus |
2.6% |
| Drug Ineffective |
2.6% |
| Unevaluable Event |
2.6% |
| Anhedonia |
2.4% |
|
| Interacting |
| Hypertension |
41.7% |
| Type 2 Diabetes Mellitus |
33.3% |
| Glaucoma |
8.3% |
| Ischaemic Heart Disease Prophylaxis |
8.3% |
| Pain |
8.3% |
|
| Renal Failure Acute |
50.0% |
| Weight Decreased |
50.0% |
|
